Meanwhile, new report counts low- and medium-access physicians
To help drug sales reps enhance their credibility with the medical community, CMR Institute (Roanoke, VA) has launched an e-learning educational program covering such topics as anatomy, pharmacology, disease state management, evidence-based medicine, and outcomes management. The institute considers these topics “key knowledge areas valued by physicians,” according to an announcement. Some 35 condensed modules are available, each intended to take 30 to 45 minutes to complete.
Beleaguered drug sales reps need all the help they can get these days. Sales activity plans at many companies continue to call for visits to doctors who either rarely or never see representatives, according to the Spring 2009 edition of the AccessMonitor report from global consulting firm ZS Associates (Evanston, IL). Thirteen percent of all pharmaceutical sales calls in the United States cannot be completed because physicians limit the number of times they see even the best pharmaceutical representatives.
The report classifies 23% of doctors as “medium access,” meaning they will see reps but are still difficult to reach: approximately half of the reps who visit these doctors fail to get in the door. About 6% of physicians in the country fell into the “low access” category, which means they will not see representatives from any company. The report also shows particularly high restrictions in Boston, Minneapolis, and parts of Wisconsin and the Northwest (including Seattle and Portland). In these areas, more than 20% of doctors are difficult to see.
“The pharmaceutical industry is facing multiple challenges, from increasingly restricted physician access to public questioning of the value of the representative role,” says Cherie Hicks, CMR Institute’s president and CEO, in an announcement. “Independent verification of competency is a first step in answering the criticism leveled by those calling for greater transparency in marketing practices.”
The e-learning curriculum is called 4C, for the core competencies, capabilities, and credibility required to be an effective, highly regarded representative. Upon successful completion of the program, representatives earn a medical representative certificate of professional competency.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.